UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Exercise in Health and Chronic Obstructive Pulmonary Disease

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Other: Knee-extensor exercise test
Other: Exercise test with restricting/releasing blood flow
Other: Exercise test with variable oxygen concentration and MRI
Other: Exercise test with oral antioxidant or placebo cocktail

First Posted Date: 2014-11-24

Last Posted Date: 2016-06-01

Lead Sponsor: University of Utah

Target Recruit Count: 185

Registration Number: NCT02300064

Locations: 🇺🇸
Veterans Affairs Salt Lake City Heath Care System, Salt Lake City, Utah, United States

Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis

Not Applicable

Terminated

Conditions: Secondary Progressive Multiple Sclerosis

Interventions: Drug: SoluMedrol
Device: Extracorporeal Photopheresis

First Posted Date: 2014-11-20

Last Posted Date: 2019-08-14

Lead Sponsor: University of Utah

Target Recruit Count: 13

Registration Number: NCT02296346

Locations: 🇺🇸
University of Michigan Health Systems, Ann Arbor, Michigan, United States

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Phase 1

Completed

Conditions: Epilepsy

Interventions: Drug: Cannabidiol

First Posted Date: 2014-11-10

Last Posted Date: 2020-01-27

Lead Sponsor: University of Utah

Target Recruit Count: 26

Registration Number: NCT02286986

Locations: 🇺🇸
University of Utah School of Medicine, Salt Lake City, Utah, United States

Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Phase 2

Terminated

Conditions: Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer

Interventions: Drug: regorafenib

First Posted Date: 2014-10-30

Last Posted Date: 2017-10-06

Lead Sponsor: University of Utah

Target Recruit Count: 1

Registration Number: NCT02278783

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)

Phase 1

Completed

Conditions: Newly Diagnosed High Grade Glioma

Interventions: Drug: Minocycline with chemoradiation (temozolomide and radiation therapy)

First Posted Date: 2014-10-22

Last Posted Date: 2019-06-19

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT02272270

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

Phase 1

Terminated

Conditions: Advanced GI Cancer

Interventions: Drug: MK-3475

First Posted Date: 2014-10-20

Last Posted Date: 2018-11-13

Lead Sponsor: University of Utah

Target Recruit Count: 39

Registration Number: NCT02268825

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Gonadal Radiation Exposure and Risk Secondary to Fluoroscopic Imaging During Trauma Surgery

Completed

Conditions: Pelvic Injuries
Hip Fractures
Femur Fractures
Acetabular Fractures

Interventions: Procedure: Exposure Recording

First Posted Date: 2014-10-17

Last Posted Date: 2023-11-03

Lead Sponsor: University of Utah

Target Recruit Count: 135

Registration Number: NCT02267330

Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients

Not Applicable

Completed

Conditions: Pancreatic Cancer

Interventions: Device: PET/CT scan to assess treatment efficacy

First Posted Date: 2014-09-19

Last Posted Date: 2021-10-15

Lead Sponsor: University of Utah

Target Recruit Count: 9

Registration Number: NCT02245217

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Phase 2

Terminated

Conditions: Upper GI Cancer

Interventions: Drug: regorafenib

First Posted Date: 2014-09-16

Last Posted Date: 2018-01-11

Lead Sponsor: University of Utah

Target Recruit Count: 5

Registration Number: NCT02241720

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Mind-Body Intervention for Veterans With PTSD

Not Applicable

Terminated

Conditions: Stress Disorders, Post-Traumatic

Interventions: Behavioral: Mind-Body Bridging

First Posted Date: 2014-08-25

Last Posted Date: 2018-05-07

Lead Sponsor: University of Utah

Target Recruit Count: 47

Registration Number: NCT02224989

Locations: 🇺🇸
Salt Lake City Veterans Affairs Health Care System, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy